FIELD: veterinary science.
SUBSTANCE: group of inventions refers to veterinary science and can be used for vaccination of animals against feline leukemia virus (FeLV). Disclosed composition contains an expression vector containing the first polynucleotide coding optimised polypeptide of FeLV feline leukemia viral envelope and the second polynucleotide coding the GAG/PRO FeLV polypeptide. Present invention also relates to vectors, which contain and express FeLV antigens, and kits for vaccination.
EFFECT: using the inventions enables inducing the immune response against FeLV.
23 cl, 2 tbl, 29 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CTLA-4 OR FELINE CD86 AND ITS APPLYING | 1999 |
|
RU2244006C2 |
| VACCINE AGAINST FELINE LEUKEMIA VIRUS | 2018 |
|
RU2784533C2 |
| FORMULA OF FELINE VACCINE | 2002 |
|
RU2312676C2 |
| RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
| DNA PLASMIDS SHOWING HIGH EXPRESSION AND STABILITY | 2007 |
|
RU2456346C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
| COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
| FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
| RECOMBINANT VACCINES AGAINST BLUETONGUE VIRUS, THEIR USE | 2011 |
|
RU2575599C2 |
